Wednesday Jul 16
Diabetes Drug Pioglitazone May Lower Risk of Alzheimer's Disease
According to a report from Reuters, a new German study has suggested that treatment with the diabetes drug pioglitazone may reduce the risk of developing Alzheimer's disease , although conclusive proof could be years away.
German database study hints diabetes drug cuts Alzheimer's risk
A large German study is the latest clinical trial to suggest that a cheap generic treatment for diabetes can stave off symptoms of Alzheimer's disease, although conclusive proof from a more formal trial could be about five years away.
Takeda Pharmaceutical Co. Ltd. And Zinfandel Pharmaceuticals Inc. To ...
Takeda Pharmaceutical Company Limited and its partner, Zinfandel Pharmaceuticals, Inc. , will present data during multiple poster and oral sessions at the upcoming Alzheimer's Association International ConferenceA 2014 , taking place in "Studies show that individuals with mild cognitive impairmenta slight, although noticeable and measurable decline ... (more)
Inflammatory genes in epicardial fat contiguous with coronary...
Inflammatory genes in epicardial fat contiguous with coronary atherosclerosis in the metabolic syndrome and type 2 diabetes: changes associated with pioglitazone.
Legal-Bay Lawsuit Settlement Funding Reports $9 Billion in the first Actos (Pioglitazone) Settlement
Legal-Bay LLC, the Lawsuit Settlement Funding Company, disclosed today a new-implemented program involving lawsuit cash advances for clients facing complications due to risky Actos prescription drugs.